Data / Form D filings / AMBIT BIOSCIENCES CORP
AMBIT BIOSCIENCES CORP: Form D filings
AMBIT BIOSCIENCES CORP, a pharmaceuticals company in San Diego, CA, filed 7 Form D notices with the SEC between 2009 and 2012. The latest, on November 9, 2012, reports $22.2 million sold of a $44.8 million offering to 16 investors.
Find out what AMBIT BIOSCIENCES CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4215 SORRENTO VALLEY BLVD., San Diego, CA, 92121
- Phone
- (858) 334-2100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1131543
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2012 | New notice | $44,814,271 | $22,206,064 | $22,608,207 | 16 | Oct 25, 2012 | sec.gov |
| May 30, 2012 | New notice | $11,482,825 | $7,066,803 | $4,416,022 | 16 | May 18, 2012 | sec.gov |
| Jul 11, 2011 | New notice | $30,026,638 | $22,000,006 | $8,026,632 | 20 | May 18, 2011 | sec.gov |
| Oct 15, 2010 | New notice | $15,913,126 | $14,999,327 | $913,799 | 18 | Sep 30, 2010 | sec.gov |
| Apr 15, 2010 | New notice | $13,440,000 | $12,000,000 | $1,440,000 | 2 | Mar 31, 2010 | sec.gov |
| Jul 30, 2009 | New notice | $2,360,980 | $0 | $2,360,980 | 1 | Jul 8, 2009 | sec.gov |
| Jun 29, 2009 | New notice | $19,717,220 | $6,428,542 | $13,288,678 | 13 | Jun 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael A. Martino | Executive Officer, Director | |
| Athena M. Countouriotis | Executive Officer | |
| David P. Bonita | Director | |
| Steven A. Elms | Director | |
| Isai M. Peimer | Director | |
| Standish M. Fleming | Director | |
| Faheem M. Hasnain | Director | |
| Alan M. Fuhrman | Executive Officer | |
| Saiid M. Zarrabian | Director | |
| Allan M. Marchington | Director | |
| Joseph M. Regan | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 5, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AMBIT BIOSCIENCES CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.